SAB BIOTHERAPEUTICS INC's ticker is and the CUSIP is 78397T103. A total of 38 filers reported holding SAB BIOTHERAPEUTICS INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $9,706 | -32.4% | 15,406 | -11.0% | 0.00% | – |
| Q2 2023 | $14,364 | +88.7% | 17,306 | 0.0% | 0.00% | – |
| Q1 2023 | $7,614 | -25.0% | 17,306 | +0.6% | 0.00% | – |
| Q4 2022 | $10,150 | -43.6% | 17,207 | -31.4% | 0.00% | – |
| Q3 2022 | $18,000 | -50.0% | 25,071 | +1.3% | 0.00% | – |
| Q2 2022 | $36,000 | -62.1% | 24,752 | -0.8% | 0.00% | – |
| Q1 2022 | $95,000 | -62.3% | 24,964 | -22.6% | 0.00% | – |
| Q4 2021 | $252,000 | – | 32,240 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INSTITUTIONAL & FAMILY ASSET MANAGEMENT, LLC | 78,115 | $294,000 | 0.05% |
| Shaolin Capital Management LLC | 275,000 | $1,034,000 | 0.03% |
| Spectrum Management Group, LLC | 5,030 | $19,000 | 0.00% |
| Veritable, L.P. | 43,551 | $164,000 | 0.00% |
| ALPS ADVISORS INC | 45,083 | $170,000 | 0.00% |
| ETF MANAGERS GROUP, LLC | 13,187 | $34,000 | 0.00% |
| Qube Research & Technologies Ltd | 24,179 | $91,000 | 0.00% |
| NORTHERN TRUST CORP | 44,476 | $167,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 301,110 | $1,132,000 | 0.00% |